Intercure Ltd. (INCR) income statement
INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 3/30
$4.46−0.11 (-2.41%)
Close on Oct 19, 2026Market cap $243.88MP/E –Yield –
Intercure Ltd. income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY2025
- Gross margin
- 12.3%
- Operating margin
- -10.1%
- Net margin
- -13.2%
- Return on equity, FY2025
- -9.0%
Financial strength
- Current ratio
- –
- Debt to equity
- 0.49
- Debt to assets
- 28.3%
- Cash to current liabilities
- 21.7%
Valuation
- P/E ratio
- –
- Price to sales
- 2.95
- Price to book
- 2.01
- Dividend yield
- –
See a number that looks wrong?